RESPONSE SURFACE METHODOLOGY-AIDED DEVELOPMENT OF PIRFENIDONE-LOADED SOLID LIPID NANOPARTICLES FOR INTRAPULMONARY DRUG DELIVERY SYSTEM
Open Access
- 7 July 2024
- journal article
- research article
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 283-290
Abstract
Objective: This study aims to determine the optimized Pirfenidone-loaded Solid Lipid Nanoparticles (P-SLN) formula for Intrapulmonary Drug Delivery System (IPDDS) using Response Surface Methodology (RSM). Methods: Box-Behnken design was applied to create fifteen P-SLN formulas comprising three independent variables, namely lipid-to-drug ratio, polymer type, and polymer concentration, and three dependent variables, including particle size, Polydispersity Index (PDI), and entrapment efficiency. The P-SLNs were prepared by solvent injection followed by the ultrasonication method. Those formulas were optimized with the RSM approach using the Design Expert®. Then, the optimized P-SLN was further characterized for morphology, moisture content, aerodynamic performance, and dissolution profile. Results: The optimization process, assisted by RSM, determined that the optimized P-SLN had a lipid-to-drug ratio of 6:1 and contained 0.5% Plasdone K-29/32. The resulting P-SLN had a spherical shape with a particle size of 212.7 nm, a PDI of 0.39, an entrapment efficiency of 95.02%, and a low moisture content of 1.59%. The optimized P-SLN also exhibited appropriate IPDDS required characteristics, including a Mass Median Aerodynamic Diameter (MMAD) ranging from 0.540–12.122 μm and a Respirable Fraction (RF) of 12.4%. Moreover, the release of pirfenidone from this optimized formula was 89.61% and 69.28% in pH 4.5 and 7.4 buffer media, respectively, in 45 min through a combination of diffusion and polymer swelling mechanisms. Conclusion: The optimized P-SLN showed promising potential as an IPDDS for pirfenidone.Keywords
This publication has 32 references indexed in Scilit:
- Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospectsLife Sciences, 2021
- Quality control and testing evaluation of pharmaceutical aerosols2020
- Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition studyMaterials Science and Engineering: C, 2019
- Micromechanical analysis on the compaction of tetrahedral particlesChemical Engineering Research and Design, 2018
- Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregatesJournal of Controlled Release, 2018
- Idiopathic pulmonary fibrosisNature Reviews Disease Primers, 2017
- Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluationInternational Journal of Pharmaceutics, 2017
- Photosafety assessments on pirfenidone: Photochemical, photobiological, and pharmacokinetic characterizationJournal of Photochemistry and Photobiology B: Biology, 2013
- Chitosan microspheres as an alveolar macrophage delivery system of ofloxacin via pulmonary inhalationInternational Journal of Pharmaceutics, 2013
- Delivery of rifampicin–PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosisJournal of Controlled Release, 2010